Cambridge, UK, Krakow, Poland, May 5, 2015 / B3C newswire / — Selvita (WSE: SLV),  a global drug discovery company with offices in the US and Poland, is opening its first office in the United Kingdom. The office is based in Cambridge, considered to be one of the most significant biotechnology clusters in the world. The new office will be responsible for supporting the ongoing projects for the customers from the UK and Northern Ireland, as well as seeking new collaboration opportunities in the area of integrated drug discovery services with pharma and biotech companies in the region. Selvita Ltd. will be focused on supporting and developing business relationships with local partners whereas Selvita’s laboratories remain in Krakow, Poland.

http://scanbalt.org/press/news+archive/view?id=3343